ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    Current Treatments for Small Hepatocellular Carcinoma: A Network Meta-Analysis of Randomized Controlled Trials.

    Z. Guo, Z. Zheng, X. He, G. Chen.

    The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

    Purpose: Numerous randomized controlled trials (RCTs) concerning treatments for small hepatocellular carcinoma (HCC) have been reported. Herein, we conducted a network meta-analysis integrating current evidence…
  • 2017 American Transplant Congress

    Precise Antibody Characterization Using Multiple Solid Phase Assay Platforms Is Critical for Accurate Virtual Crossmatching.

    D. Li,1 O. Timofeeva,1 M. Awwad,1 C. Cody,2 S. Najjar,2 S. Rosen-Bronson.1

    1Histocompatibility Laboratory, MedStar Georgetown University Hospital, Washington, DC; 2MedStar Heart Institute, Washington Hospital Center, Washington, DC

    Purpose: Virtual crossmatch (VXM) has been utilized in heart transplant (txp) for more than a decade. Many labs base the VXM solely on single antigen…
  • 2017 American Transplant Congress

    Graft Survival in De Novo Donor-Specific Antibodies and Positive Flow Crossmatch Kidney Transplants Is influenced by Class I and Class II.

    S. Montag,1,2 B. Ho,1 H. Bhagat,3 E. Lee,3,4 K. Atiemo,1 A. Daud,1 R. Kang,1 L. Zhao,1,2 J. Schwartz,3 D. Ladner.1

    1Northwestern University Transplant and Outcomes Research Collaborative (NUTORC), Chicago; 2Dept of Preventive Medicine, Northwestern University, Chicago; 3Astellas Pharma Global Development, Northbrook; 4Now with UCB, Atlanta

    Patients with de novo donor-specific antibodies (dnDSA) show inferior graft survival in numerous small studies. We assessed the effect of dnDSA on graft and patient…
  • 2017 American Transplant Congress

    Infusion of Polyclonal Tregs Modulates Subclinical Kidney Transplant Inflammation: Final Report of TASK Pilot Trial.

    S. Chandran, Q. Tang, M. Sarwal, Z. Laszik, A. Putnam, T. Sigdel, E. Tavares, J. Bluestone, F. Vincenti.

    UCSF, San Francisco

    Purpose:Treg therapy can reverse established inflammation in animal models. We conducted a pilot safety & feasibility trial of Treg therapy for subclinical kidney transplant inflammation.Methods:Peripheral…
  • 2017 American Transplant Congress

    Pre-Transplant Circulating TNFR2+ Regulatory T Cells Predict Acute Rejection within the First 6 Months After Kidney Transplantation.

    M.-T. Nguyen,1 S. Sahakian,2 S. Liu,2 Y. Wang,2 J. Tchervenkov,2 S. Paraskevas.2

    1Department of Surgery, Columbia University, New York, NY; 2Department of Surgery, McGill University, Montreal, QC, Canada

    Background: Acute rejection (AR) mostly occurs during the first 6 months after kidney transplantation and contributes importantly to graft loss. Diagnosis relies on changes in…
  • 2017 American Transplant Congress

    Molecular Analysis of Acute Rejection in Formalin-Fixed Paraffin-Embedded Clinical Face Transplant Biopsies.

    T. Win,1 B. Dyring-Andersen,1 V. Barrera,2 S. Ho Sui,2 R. Lopdrup,1 H. Kiwanuka,1 N. Murakami,1 J. Teague,1 E. Lowry,1 E. Bueno,1 A. Chandraker,1 L. Riella,1 B. Pomahac,1 R. Clark.1

    1Brigham and Women's Hospital, Boston, MA; 2Harvard T.H. Chan School of Publich Health, Boston

    BackgroundDiagnosis of acute rejection in face transplants relies on the histological evaluation of allograft skin biopsies using BANFF classification, an approach with significant limitations including…
  • 2017 American Transplant Congress

    Necroptotic Cellular Death Modulates TNFα Mediated Inflammation and Cardiac Allograft Rejection in Mice.

    R. Ang, P. Heeger, A. Ting.

    Immunology Institute, Icahn School of Medicine at Mount Sinai, NYC, NY

    While graft injury following cold ischemia reperfusion (IR) can accelerate graft rejection, mechanisms are incompletely understood. Evidence indicates that posttransplant IR injury is associated with…
  • 2017 American Transplant Congress

    A Search for a Biomarker Which Predicts Belatacept-Resistant Rejection.

    G. de Graav,1 C. Baan,1 M. Clahsen-van Groningen,2 R. Kraaijeveld,1 M. Dieterich,1 W. Verschoor,1 D. Roelen,3 M. Cadogan,1 J. van de Wetering,1 J. van Rosmalen,4 W. Weimar,1 D. Hesselink.1

    1Internal Medicine, Erasmus University Medical Center, Rotterdam, South Holland, Netherlands; 2Pathology, Erasmus University Medical Center, Rotterdam, South Holland, Netherlands; 3Immunohematology and Blood Transfusion, Erasmus University Medical Center, Rotterdam, South Holland, Netherlands; 4Biostatistics, Erasmus University Medical Center, Rotterdam, South Holland, Netherlands

    Belatacept, an inhibitor of the CD28-CD80/86 costimulatory pathway, has been associated with a higher acute rejection risk than ciclosporin. We sought to identify a biomarker…
  • 2017 American Transplant Congress

    Assessment of Attitudes Toward Use of Hepatitis C Positive Liver Allografts in US Transplant Centers.

    S. Kilaru,1 E. Tapper,2 M. Curry.3

    1Medicine, NYU School of Medicine, New York, NY; 2Medicine, University of Michigan, Ann Arbor, MI; 3Medicine, Beth Israel Deaconess Medical Center, Boston, MA

    Background:Direct-acting antivirals (DAAs) have been shown to have high cure rates in hepatitis C (HCV)-positive liver transplantation (LT) recipients. The organ donor shortage has led…
  • 2017 American Transplant Congress

    Knowledge and Attitudes Associated with Willingness to Accept HIV+ Organs Among Persons Living with HIV.

    S. Anjum, S. Halpern, K. Kumar, A. Nyugen, S. Rasmussen, A. Massie, A. Tobian, D. Segev, J. Sugarman, C. Durand.

    Surgery, Johns Hopkins, Baltimore

    HIV-to-HIV organ transplants are a novel treatment for organ failure in HIV-positive (HIV+) individuals. However, attitudes of potential HIV+ recipients regarding HIV+ donors remain unknown.Methods:…
  • « Previous Page
  • 1
  • …
  • 78
  • 79
  • 80
  • 81
  • 82
  • …
  • 181
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences